Proteomics International Laboratories Ltd
ASX:PIQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
AU |
|
C
|
CviLux Corp
TWSE:8103
|
TW |
|
Gosun Holding Co Ltd
SZSE:000971
|
CN |
|
Prim SA
F:5P1
|
ES |
|
Advanced Info Service PCL
OTC:AVIZF
|
TH |
|
M
|
MegaMD Co Ltd
KOSDAQ:133750
|
KR |
|
D
|
Dalata Hotel Group PLC
F:DHG
|
IE |
|
M
|
Myanmar Strategic Holdings Ltd
LSE:SHWE
|
SG |
|
Nhoa SA
PAR:NHOA
|
FR |
|
Investco Corp
OTC:IVCO
|
US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
US |
|
Samaraenergo PAO
MOEX:SAGO
|
RU |
|
SBC Exports Ltd
NSE:SBC
|
IN |
|
M
|
Myrexis Inc
OTC:MYRX
|
US |
|
Z
|
Zhejiang Walrus New Material Co Ltd
SZSE:003011
|
CN |
|
Reko International Group Inc
XTSX:REKO
|
CA |
|
A
|
American Express Co
BMV:AXP
|
US |
|
Saudi Public Transport Company SJSC
SAU:4040
|
SA |
Cash Flow Statement
Cash Flow Statement
Proteomics International Laboratories Ltd
| Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Cash Taxes Paid |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Cash Interest Paid |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Change in Working Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Cash from Operating Activities |
(2)
N/A
|
(1)
+12%
|
(1)
-11%
|
(1)
+31%
|
(1)
-7%
|
(1)
-30%
|
(2)
-18%
|
(2)
-9%
|
(0)
+79%
|
(0)
+23%
|
(2)
-644%
|
(3)
-38%
|
(4)
-16%
|
(4)
-18%
|
(6)
-36%
|
(5)
+9%
|
(6)
-8%
|
(5)
+2%
|
(7)
-21%
|
(6)
+4%
|
|
| Investing Cash Flow | |||||||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(2)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
+29%
|
(0)
-1 370%
|
(0)
-16%
|
(0)
+70%
|
1
N/A
|
1
+2%
|
(1)
N/A
|
(2)
-17%
|
(0)
+84%
|
(0)
+26%
|
(0)
-22%
|
(0)
+45%
|
(1)
-778%
|
(1)
-2%
|
(0)
+61%
|
(0)
+16%
|
(0)
+88%
|
(0)
+36%
|
(2)
-6 863%
|
|
| Financing Cash Flow | |||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
2
|
2
|
0
|
3
|
3
|
0
|
3
|
3
|
6
|
6
|
0
|
0
|
8
|
11
|
4
|
7
|
6
|
11
|
11
|
|
| Net Issuance of Debt |
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other |
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
|
| Cash from Financing Activities |
0
N/A
|
2
+1 787%
|
2
-5%
|
(0)
N/A
|
3
N/A
|
3
+4%
|
(0)
N/A
|
3
N/A
|
3
+4%
|
6
+100%
|
6
0%
|
0
-95%
|
0
-38%
|
8
+4 217%
|
11
+42%
|
4
-65%
|
7
+73%
|
6
-11%
|
11
+88%
|
11
-2%
|
|
| Change in Cash | |||||||||||||||||||||
| Net Change in Cash |
(1)
N/A
|
1
N/A
|
0
-66%
|
(1)
N/A
|
2
N/A
|
2
+45%
|
(1)
N/A
|
(0)
+42%
|
1
N/A
|
5
+496%
|
3
-36%
|
(3)
N/A
|
(3)
-17%
|
2
N/A
|
4
+72%
|
(2)
N/A
|
1
N/A
|
0
-42%
|
4
+1 136%
|
2
-47%
|
|
| Free Cash Flow | |||||||||||||||||||||
| Free Cash Flow |
(2)
N/A
|
(1)
+12%
|
(2)
-21%
|
(1)
+27%
|
(1)
+4%
|
(1)
-29%
|
(2)
-17%
|
(3)
-86%
|
(2)
+38%
|
(1)
+71%
|
(2)
-324%
|
(3)
-36%
|
(4)
-12%
|
(5)
-45%
|
(7)
-30%
|
(6)
+17%
|
(6)
-5%
|
(6)
+8%
|
(7)
-20%
|
(8)
-27%
|
|